Leading drugmakers plan to work together to accelerate development of an Ebola vaccine and produce millions of doses of the most effective experimental product for use next year.
Read more »
Shire's (SHP.L) own deal-making capacity is likely to push the drugmaker's annual sales "way north" of the $10 billion it is currently forecasting for 2020 on the basis of the existing portfolio, its chief executive said on Monday.
U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion battle for Britain's AstraZeneca Plc after having two bids rejected, as deal-making grips the healthcare industry.
With more compliance officers in China than in any country bar the United States, British drug maker GlaxoSmithKline Plc seemed well-positioned to do things right.
Two men with HIV have been off AIDS drugs for several months after receiving stem-cell transplants for cancer that appear to have cleared the virus from their bodies, researchers reported on Wednesday.
